Evaluation of a 64Cu-labeled 1,4,7-triazacyclononane, 1-glutaric acid-4,7 acetic acid (NODAGA)-galactose-bombesin analogue as a PET imaging probe in a gastrin-releasing peptide receptor-expressing prostate cancer xenograft model

Min Hwan Kim, Ji Ae Park, Sang Keun Woo, Kyo Chul Lee, Gwang Il An, Byoung Soo Kim, Kwang Il Kim, Tae Sup Lee, Chan Wha Kim, Kyeong Min Kim, Joo Hyun Kang, Yong Jin Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gastrin-releasing peptide receptor (GRPR) is overexpressed by a variety of human tumors and in particular, identified to be upregulated in prostate cancers. The current study aimed to develop clinically translatable BBN analogue-based radioligands for positron emission tomography (PET) of GRPR-positive tumors. We developed radiolabeled BBN analogues and modified radiolabeled galacto-BBN analogues and then investigated their tumor-targeting efficacy in vivo. The chelator 1,4,7-triazacyclononane, 1-glutaric acid-4,7 acetic acid (NODAGA) was used to radiolabel the peptides with 64Cu. The peptides were evaluated by measuring cell-based receptor-binding affinities. Biodistribution experiments and small animal imaging using PET were performed in nude mice bearing subcutaneous PC3 human prostate cancer xenografts. The conjugates were radiolabeled with yields >99%. The stability assay showed that [64Cu]NODAGA-BBN and [64Cu]NODAGA-galacto-BBN remained stable in both human and mouse serum for 1 h at 37°C. PET images of PC3 tumor-bearing nude mice were acquired at 1, 3, 24, 48 and 72 h after injection. [64Cu]NODAGA-galacto-BBN showed retention in tumors for 72 h, low liver uptake, and rapid renal clearance. PET imaging results were also confirmed by biodistrubution 1 and 3 h after injection. [64Cu]NODAGA-BBN and [64Cu]NODAGA-galacto-BBN are promising new PET probes for GRPR-positive prostate cancer.

Original languageEnglish
Pages (from-to)1159-1168
Number of pages10
JournalInternational journal of oncology
Volume46
Issue number3
DOIs
Publication statusPublished - 2015 Mar 1

Keywords

  • Bombesin
  • Cu
  • Positron emission tomography
  • Prostate cancer
  • Radiopharmaceuticals

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Evaluation of a <sup>64</sup>Cu-labeled 1,4,7-triazacyclononane, 1-glutaric acid-4,7 acetic acid (NODAGA)-galactose-bombesin analogue as a PET imaging probe in a gastrin-releasing peptide receptor-expressing prostate cancer xenograft model'. Together they form a unique fingerprint.

  • Cite this